Publication | Closed Access

A population pharmacokinetic evaluation of the influence of CYP2D6 genotype on risperidone metabolism in patients with acute episode of schizophrenia

PsychiatryCyp2d6 GenotypeMedicinePsychotropic MedicationPsychopharmacologySchizophreniaRisperidone MetabolismAcute EpisodePharmacotherapyPharmacologyPsychotic Disorder